Lymphoma Clinical Trials in Arizona

Showing 461-465 of 465 trials

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

NCT00061672

The primary objective of this study is to assess the safety and effectiveness of ABT-510 in subjects with refractory lymphoma.

Lymphoma, Non-HodgkinHodgkin's Lymphoma

Abbott67 participantsStarted Apr 2003

Phoenix, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +11 more locations

COMPLETEDPhase 342 miles

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

NCT00039910

Intensive chemotherapy is associated with significant thrombocytopenia, often requiring platelet transfusion to maintain platelet counts. This investigational drug has been demonstrated to increase platelet counts. This study will test the safety and efficacy of the investigational drug in the prevention of thrombocytopenia in patients with recurrent or refractory intermediate-grade or high-grade non-Burkitt's, non-Hodgkin's lymphoma (NHL), or Hodgkin's disease receiving DHAP (Dexamethasone, high-dose Cytarabine, and Cisplatin) chemotherapy.

Non-Hodgkin LymphomaHodgkin DiseaseThrombocytopenia

Pfizer240 participantsStarted Jul 2000

Phoenix, Arizona, United States • La Jolla, California, United States • Loma Linda, California, United States +35 more locations

PreviousPage 24 of 24

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Lymphoma Trials in Other Cities

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

Other Conditions in Arizona